News Focus
News Focus
Followers 0
Posts 36
Boards Moderated 0
Alias Born 03/09/2017

Re: Bickema post# 18366

Thursday, 04/12/2018 11:33:20 AM

Thursday, April 12, 2018 11:33:20 AM

Post# of 20689
Teva must be very aggressively offering incentives to the Pharmacy benefit managers to stay on their original formulation. Novartis may be waiting to see how the market develops with three players in the market. It has only been a month. I was surprised..